FANCG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.000400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.206180E-01
Normal-vs-Stage2
6.170000E-01
Normal-vs-Stage3
2.390000E-02
Normal-vs-Stage4
9.351400E-01
Stage1-vs-Stage2
4.175800E-01
Stage1-vs-Stage3
2.562000E-02
Stage1-vs-Stage4
5.562400E-01
Stage2-vs-Stage3
1.728800E-01
Stage2-vs-Stage4
6.440600E-01
Stage3-vs-Stage4
1.487570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.314400E-01
Normal-vs-AfricanAmerican
9.524400E-02
Normal-vs-Asian
3.752200E-01
Caucasian-vs-AfricanAmerican
2.305000E-01
Caucasian-vs-Asian
8.740200E-01
AfricanAmerican-vs-Asian
2.933400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.265000E-01
Normal-vs-Female
3.293200E-01
Male-vs-Female
3.968200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.494100E-02
Normal-vs-Age(41-60Yrs)
9.817800E-01
Normal-vs-Age(61-80Yrs)
2.121600E-01
Normal-vs-Age(81-100Yrs)
3.359000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.540800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.886800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.383790E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.980100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.854200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.545400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.183780E-01
Normal-vs-Daily Drinker
9.281400E-01
Normal-vs-Weekly Drinker
8.588400E-01
Normal-vs-Occasional Drinker
5.274200E-01
Normal-vs-Social Drinker
8.346000E-01
Non Drinker-vs-Daily Drinker
1.730410E-01
Non Drinker-vs-Weekly Drinker
3.295700E-02
Non Drinker-vs-Occasional Drinker
1.065240E-01
Non Drinker-vs-Social Drinker
1.330430E-02
Daily Drinker-vs-Weekly Drinker
6.931400E-01
Daily Drinker-vs-Occasional Drinker
4.554600E-01
Daily Drinker-vs-Social Drinker
6.952800E-01
Weekly Drinker-vs-Occasional Drinker
5.146600E-01
Weekly Drinker-vs-Social Drinker
9.702800E-01
Occasional Drinker-vs-Social Drinker
4.223800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.482000E-01
Normal-vs-Grade 2
7.640600E-01
Normal-vs-Grade 3
6.882400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.364000E-01
Grade 1-vs-Grade 3
2.240600E-01
Grade 1-vs-Grade 4
7.482000E-01
Grade 2-vs-Grade 3
2.877200E-01
Grade 2-vs-Grade 4
7.640600E-01
Grade 3-vs-Grade 4
6.882400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.609400E-01
Normal-vs-NonDiabetic
7.098000E-01
Diabetic-vs-NonDiabetic
2.113600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.039400E-01
Normal-vs-NoPancreatitis
6.296600E-01
Pancreatitis-vs-NoPancreatitis
4.454200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.848600E-01
Normal-vs-N1
6.020600E-01
N0-vs-N1
3.833400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.590000E-01
Normal-vs-TP53-NonMutant
3.675800E-01
TP53-Mutant-vs-TP53-NonMutant
1.066960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
